Glycemic variability may signal retinal changes
-
By
-
Andrea Surnit
-
September 1, 2026
-
3 min
By
Andrea Surnit
September 1, 2026
by Chaofeng Yuan, Yue Hao, Jianghui Wang, Chuanxi Wang, Zhengxuan Jiang
June 26, 2026
Although the trial missed its primary endpoint, exploratory analyses suggested slower lesion growth and better functional outcomes with gildeuretinol.
July 20, 2026
A 20-week INSIGHT extension suggests that switching from reference aflibercept to MYL-1701P maintained comparable safety, visual, and anatomic outcomes in patients with diabetic macular edema.
July 20, 2026